Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10969412 | Vaccine | 2012 | 12 Pages |
Abstract
⺠MIP provides long-term protection as compared to BCG against tuberculosis. ⺠Improved granulomatous immune response in MIP-group during chronic infection. ⺠Higher early protective Th1 immune response after M.tb infection in MIP-group. ⺠MIP-aerosol induced local lung as well as systemic protective immune response. ⺠MIP is safe and more effective in live form, causes no untoward reaction.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ankan Gupta, F.J. Ahmad, Faiz Ahmad, U.D. Gupta, M. Natarajan, V.M. Katoch, Sangeeta Bhaskar,